Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Communications

Topics

Biology

Biochemistry

Chemistry

Medicine

Pathology

Show all topics

DOI

10.1038/s41467-021-26239-2

License

CC-BY

Other Formats

PDF